Clinical Trial Update: Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of rifalazil for the treatment of Chlamydia trachomatis infection in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Trachomatis Infection

Drugs mentioned

• Rifalazil (rifalazil)

Snippet

Sponsor: ActivBiotics Pharma, LLC | Conditions: Chlamydia Trachomatis Infection | Phase 2 | Status: COMPLETED